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Purpose: Left ventricular assist device (LVAD) therapy can be live-saving for advanced 
heart failure patients. Conventional anastomosis (surgical connection) of LVAD outflow 
grafts to the aorta requires aortic clamping and hand-suturing. Aortic clamping increases 
the risk for neurological complications. Hand-suturing may be time-consuming and 
requires significant surgical dexterity. There is currently no commercially available 
device for sutureless anastomosis of large vascular grafts (diameter > 5mm). To 
overcome these limitations, a prototype LVAD outflow graft anastomosis device (GrAD) 
that facilitates sutureless anastomosis was developed and tested to demonstrate proof-of-
concept and feasibility for (1) secured attachment withstanding physiological pressures, 
and (2) comparable attachment strength to conventionally hand-sewn sutured 
anastomosis.  
Methods: To demonstrate proof-of-concept, prototype GrADs were fabricated using a 
nitinol wire connector attached to a 15 mm graft, felt flanged cuff, and cyanoacrylate 
adhesive. To demonstrate feasibility, the GrAD was anastomosed to bovine descending 
aorta and tested in a mock flow loop over a range of static (0, 50, 100, 150, 200 mmHg) 
and dynamic pressures (normal, hypertension, heart failure, LVAD support) to quantify 
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leakage. The maximum pull-out force for the GrAD and sutured anastomosis were also 
measured after completing static and dynamic testing in the mock flow loop model. 
Results: The GrAD remained securely attached during all static and dynamic pressure 
test conditions as evidenced by minimal leak rates during clinically equivalent normal 
(22.1 ± 9.3 ml/min), hypertension (23.1 ± 10.1 ml/min), heart failure (16.4 ± 6.4 ml/min), 
and LVAD support (16.4 ± 4.3 mL/min) test conditions. Significantly larger leak rates at 
normal dynamic pressure (120/80 mmHg) between the GrAD and previously reported 
results for hand-sutured anastomosis were not observed. Differences in peak pull-out 
force between GrAD (43.57 ± 17.31 N) and hand-sutured anastomosis (63.48 ± 8.72 N) 
were statistically indiscernible (paired t-test, p < 0.5). No indications of device damage 
were observed. 
Conclusion: A prototype GrAD enabling a sutureless, adaptable, and angled LVAD 
outflow graft anastomosis was developed with preliminary feasibility testing 
demonstrating proof-of-concept. The proposed LVAD outflow GrAD may facilitate 
surgical implant by eliminating the need for hand-suturing, decrease implant time, and 
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A. Heart Failure 
 
Heart failure (HF) is a progressive condition in which the heart muscle loses its 
capacity to pump adequate blood volume to satisfy the body’s demand for oxygen and 
nutrients, and removal of carbon dioxide and waste. It continues to be one of the largest 
unsolved medical complications despite being one of the most explored medical diseases. 
HF is the leading cause of death in the United States, affecting ~5.7 million people in the 
US with a projected increase in prevalence of 46% from 2012 to 2030 (Mozaffarian et al., 
2015). In 2011, the direct and indirect costs of HF in the US was an estimated 34.4 billion 
dollars (Heidenreich et al., 2011), and is projected to increase from 44.6 to 97 billion 
from 2015 through 2030 (Roger et al., 2012). According to the National Center for 
Health Statistics (NCHS) and the National Heart, Lung, and Blood Institute (NHLBI), 
one in 9 deaths in the US have been attributed to HF. Although survival following HF 
diagnosis has improved over time due to advances in medical treatment, the death rate 
remains high with a ~50% mortality rate within 5 years of HF diagnosis (Levy et al., 
2002; V. L. Roger et al., 2004).  
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Preferred treatment strategy(s) for HF is dependent on the type of HF and 
severity. For example, symptoms are managed using pharmacologic therapy and changes 
to lifestyle factors in early stage HF. Unfortunately, there is a large group of patients with 
severe HF (advanced HF) that are unresponsive to pharmacologic therapy and changes in 
lifestyle factors. The gold standard for treating these advanced HF patients is heart 
transplantation, but the supply of donor hearts cannot satisfy the clinical demand. In 
2013, only 51.1% of candidates listed for heart transplantation received heart transplants 
(Colvin-Adams et al., 2014). The number of heart transplants has reached a plateau while 
the number of advanced HF patients continues to grow (Figure 1).  Subsequently, there is 
a significant unmet clinical need and demand for alternative HF treatment options.  
 
 
Figure 1: Number of heart transplants performed in North America, Europe and other countries as reported 
by the International Society for Heart & Lung Transplantation Transplant Registry (Stehlik et al., 2010). 
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B. Left Ventricular Assist Device (LVAD) 
 
 Left ventricular assist devices (LVADs) are blood pumps that assist the blood 
pumping function of the heart in advanced heart failure patients (Figure 2). In 2006, the 
Interagency Registry for Mechanically Assisted Circulatory Support Devices 
(INTERMACS) reported 94 LVAD implants per year, which increased to 2,447 LVAD 
implants per year in 2014 (Kirklin et al., 2015). LVADs were initially implanted as 
bridge to transplantation (BTT) devices for patients with deteriorating HF that were at 
high mortality risk while on the waiting list wait for a heart transplant.  Due to early 
success and technical advances in LVAD technology over the past 15 years, the use of 
these devices has expanded to include long-term and myocardial recovery therapy.   
Figure 2: Number of left ventricular assist device (LVAD) and total artificial heart implants from 2006-
2014 as reported by the Interagency Registry for Mechanically Assisted Circulatory Support Devices 
(Kirklin et al., 2014). 
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LVAD technology has evolved significantly from first-generation devices that 
were large, pulsatile, volume displacement pumps to current third-generation devices that 
are smaller size, lighter weight, valveless, and magnetically-levitated rotary pumps. 
Technological innovations of LVADs included miniaturization of pumps, increased 
durability due to less moving parts, introduction of continuous-flow pumps, and 
magnetically levitated pump rotors. In parallel with the technological evolution of 
LVADs, there has been a marked improvement in the survival rates after LVAD 
implantation. The one-year and two-year actuarial survival rates of these continuous-flow 
devices are 68% and 58%, respectively, compared to 55% and 24% for first generation 
pulsatile-flow devices (Slaughter et al., 2009). In addition, there have been significantly 
less clinically significant adverse events (e.g. device-related infection, non-device-related 
infection, right heart failure, respiratory failure, renal failure, cardiac arrhythmia) in 
patients with continuous-flow devices compared to pulsatile-flow devices (Slaughter et 
al., 2009).  
The success of LVADs as BTT devices combined with increased survival rates 
and reduced adverse events has expanded their clinical role to permanent (long-term) 
support devices (destination therapy). The Randomized Evaluation of Mechanical 
Assistance for the Treatment of Congestive Heart (REMATCH) trial compared optimal 
medical management (pharmacological therapy) vs Heartmate I Left Ventricular Assist 
Device LVAD as permanent treatment among 129 advanced HF patients. The LVAD 
group had a 52% one-year survival and 23% two-year survival compared to 25% one-
year survival and 8% for the optimal medical management (OMM) therapy (Rose et al., 
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2001). These results from the REMATCH trial led to Food and Drug Administration 
(FDA) approval of a few CF LVADs for destination therapy (DT).  
Clinical research has demonstrated improvements in cardiac function and reverse 
remodeling with LVAD support offering hope for LVAD use as a potential therapy 
strategy for sustained myocardial recovery (Frazier et al., 1996). Studies offer compelling 
evidence that chronic volume unloading provided by LVADs is associated with 
beneficial structural and molecular remodeling that may lead to functional improvement 
(Birks et al., 2005; Birks et al., 2006; Cullen et al., 2006; Hall et al., 2007; Latif, Yacoub, 
George, Barton, & Birks, 2007). For some patients, the reverse remodeling that occurs 
may allow for removal of the LVAD due to regained cardiac function (Birks, 2010; Birks 
et al., 2006; Dandel et al., 2005). Emma Birks et al. has pioneered the methodology of 
combining the neurohormonal effects of HF medications and mechanical left ventricular 
volume unloading with LVADs as a treatment strategy for myocardial recovery (Birks et 
al., 2006; Lenneman & Birks, 2014). This treatment method has allowed about 2/3 of a 
small cohort of patients receiving the treatment to regain cardiac function for device 
removal (Birks, 2010; Birks et al., 2006). Expanding clinical indications for LVAD 
therapy as BTT, DT, or myocardial recovery promotes a larger application and use of 
LVADs for HF patients.  
 
1. Surgical Implantation of LVADs 
 Although LVADs can be a life-saving therapy for advanced HF patients, 
implantation of these devices requires a major surgical procedure that can take up to 4+ 
hours. Conventional implantation for popular LVAD systems in the US—Thoratec 
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HeartMate II, HeartWare HVAD, Jarvik-2000—require a median sternotomy (Figure 3), 
cardiopulmonary bypass (CPB) and partial clamping of the aorta. Median sternotomy is 
associated with risk of infection, high hospital stay costs, and severe burden for the 
patient (Graf et al., 2010; Heilmann et al., 2013; Taylor, Mitchell, & Mitchell, 2012). 
CPB is associated with post-operative bleeding (Ohri et al., 1991) and/or pulmonary 
complications (Huffmyer & Groves, 2015), as well as potential risk of blood damage 
(Mamikonian et al., 2014). Clamping of the aorta has been associated with increased risk 
of neurological complications (Zamvar et al., 2002) and aortic dissections (Stanger, 
Oberwalder, Dacar, Knez, & Rigler, 2002). These limitations have led investigators to 
investigate the development of alternative surgical approaches and/or novel technologies 
that may enable less-invasive implantation techniques to reduce time and facilitate 
surgery and recovery. 
Several investigators have reported less-invasive (Figure 3) and beating heart (off-
pump; without cardiopulmonary bypass) surgeries for LVAD implantation (Anyanwu, 
Fischer, Plotkina, Pinney, & Adams, 2007; Cheung et al., 2011; Frazier, 2003; Gregoric 
et al., 2008; Maltais, Davis, & Haglund, 2014; Rojas et al., 2015; Sun et al., 2008; 
Wagner et al., 2015). For example, the Sutureless Beating Heart connector (APK 
Advanced Medical Technologies, Atlanta, GA) allows for off-pump, beating heart 
implantation of inflow cannulas of LVADs (Koenig et al., 2014). The combination of 
less-invasive surgical approaches and novel technologies may enable less-invasive and 
off-pump implantation of LVADs, thereby potentially reducing post-operative recovery 
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times, cost of hospital stays, and the risk of further complications associated with CPB 
and median sternotomy.  
2. Outflow Graft Anastomosis of LVAD 
To complete the LVAD outflow graft anastomosis (surgical connection), a side-
biting clamp is placed on the ascending aorta to facilitate suturing and minimize blood 
loss by creating an area of flow stagnation. A small incision is then made to the aorta 
(aortotomy) to connect to outflow graft. An aortic punch is typically used to round out the 
edges of the incision to prevent damage or tearing at the incision site. A 3-0 to 5-0 
Prolene suture is used to hand-suture a gelatin-impregnated, woven polyethylene 
terephthalate (PET) graft in a running suture technique (Figure 4). Upon completion of 
the suturing, the side-biting clamp is removed and blood flow provided through the 
outflow graft.  
A B 
Figure 3: Images showing different surgical approaches for implanting left ventricular assist devices 
(LVADs). A) Median sternotomy used for conventional implantation of LVADs (Zucchetta, Tarzia, 
Bottio, & Gerosa, 2014), B) Less-invasive incisions used for implantations of LVADs, also showing 
standard locations for inflow cannulation to the left ventricular apex and outflow graft anastomosis to the 
ascending aorta (Gregoric et al., 2008). 
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 Conventional LVAD outflow graft anastomosis requires aortic cross- or partial-
clamping, which as mentioned previously is associated with aortic complications. To 
complete anastomosis of the LVAD outflow graft to the aorta requires surgical dexterity 
and may be time-consuming (up to 30 minutes) to complete. As surgical implantation for 
LVADs advance toward less-invasive, off-pump procedures, alternative solutions are 
warranted for completing LVAD outflow graft anastomosis that would complement an 
altogether less-invasive procedure. 
 
Figure 4: Diagram of an end-to-side anastomosis performed using a 
running suture technique (Baker, 2015). 
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C. Sutureless Anastomosis 
Historically, anastomosis has been completed using hand-suture methods based 
on the principles established by Alexis Carrel in 1902 (Carrel, 1902). The reliability and 
long-term patency results of this method has rooted it as the gold standard for vascular 
anastomosis. Earliest scientific reports for completing sutureless anastomosis used crude 
materials (e.g. quill-pens, glass, ivory cuffs, ox shin bones) as vascular prostheses (Abbe, 
1894; Callow, 1982; Muir, 1914; Nitze, 1897; Tuffier, 1915). More promising 
technologies were introduced in the 1900s that employed interlocking rings (Berggren, 
Ostrup, & Lidman, 1987; Nakayama, Tamiya, Yamamoto, & Akimoto, 1962; Payr, 
1904), symmetrical anvils (Daniel & Olding, 1984), staples (Androsov, 1956), heat-
shrink tubing (Mattox & Wozniak, 1991), and clips (Kirsch, 1998). Less mechanical 
approaches for sutureless anastomosis included the combination of lasers with stay 
stitches (Grubbs et al., 1988; Jain & Gorisch, 1979; Phillips et al., 1999). None of these 
Figure 5: Timeline showing the chronological development of historical 
sutureless anastomosis devices (P. Tozzi, 2007). 
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devices were widely accepted due to limitations that included complex and cumbersome 
instrumentation, rigid foreign bodies, and poor clinical results (P. Tozzi, 2007).  
 
D. Devices for Sutureless Anastomosis 
Currently there are no commercially available devices for sutureless anastomosis 
of large-diameter synthetic grafts (>5 mm), similar to those used for LVAD outflow 
grafts. The majority of devices enabling sutureless anastomosis were developed for 
facilitating coronary artery bypass graft (CABG) procedures, which require end-to-side 
anastomosis of small-diameter arteries/veins (<5 mm). These devices may be categorized 
as proximal (anastomosed to the ascending aorta) or distal (anastomosed to the 
descending aorta) anastomotic devices.  
The St. Jude Medical Symmetry Aortic Connector was the first nitinol connector 
to gain clinical approval (P. Tozzi, 2007). Nitinol is a Nickel and Titanium alloy that 
exhibits superelastic and shape-memory properties enabling it to return to an original 
shape after large deformations. This star-shaped connector attaches vein grafts at a 90° 
Figure 6: Photograph of the first generation St. Jude Medical Symmetry Aortic 
Connector. Aortic wall is compressed between internal and external struts. Connection 
with the vessel is achieved with vein hooks (P. Tozzi, 2007). 
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angle to the proximal aorta by compressing the aortic wall between internal and external 
struts (Figure 6). Once a graft vein is excised, it is loaded onto the delivery system. 
Hooks arranged around the inner ring of the connector fasten to the vein. A limitation of 
this device is that only a single end of the vessel can be anastomosed since a free-end is 
required for loading onto the deployment tool. Furthermore, the 90° take-off angle 
requires precise placement of the graft vessel to avoid graft kinking. Of the 44 
anastomoses constructed by the Symmetry Aortic Connector 55% were occluded (Figure 
7) at a mean follow-up period of 41 months (P. Bergmann et al., 2007). In another study, 
74 patients underwent elective CABG in which 131 anastomoses were constructed using 
the Symmetry Aortic connector, in which 20 bypass grafts (2 hand suture, 18 Symmetry) 
showed severe stenosis or occlusion (Traverse et al., 2003). Although the Symmetry 
device reliably allows blood flow acutely through an anastomosis (Dewey et al., 2004; 
Eckstein et al., 2002), long-term clinical results discouraged the continued usage of the 
device. 
Figure 7: Photograph showing occlusion of St. Jude Medical 
Symmetry Aortic Connector one-month after implantation due 
to intima hyperplasia onto the struts (P. Tozzi, 2007). 
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 Other devices that allow anastomosis between the ascending aorta and a graft 
vessel include the CorLink (Cardiovations, Somerville, NJ) and Spyder (Coalescent 
Surgical, Sunnyvale, CA). The CorLink is a nitinol connector that requires a graft vessel 
to be everted over the end of the connector, which may be cumbersome and/or damage 
the vessel intima (innermost cellular layer in contact with blood flow), as shown in 
Figure 8. The graft vessel is pulled through an insertion tool for deployment (Figure 8). 
The mechanism of loading the vessel through the side of the integrated deployment tool 
offers the advantage of not requiring the graft to have a free-end.  For this device to 
successfully attach to a target vessel, two sets of five pins must fully-penetrate through 
the vessel. The Spyder uses a novel approach of depositing 6 nitinol sutures (U-clips) 
between a pre-mounted vein graft and the aorta, resulting in a connection similar to an 
interrupted suture technique without the requirement of tying nots. Both the Corlink and 
Spyder devices demonstrated higher incidence of occlusion versus standard suture 
anastomosis, as well as failed to create hemostasis upon deployment (Biancari et al., 
2007; Gummert et al., 2007). These devices had limited foreign body exposure, but the 
Figure 8: Drawings showing the Cardiovations CorLink device. A) CorLink device being loaded with a 
graft vessel inserted through the side of the insertion tool, vessel-end everted, and pins penetrating through 
the everted vessel (Bar-El, Tio, & Shofti, 2003), B) CorLink device deployed into the side of a vessel 




increased vascular injury from penetration of pins/clips may have alternatively triggered 
intimal hyperplasia (proliferation of intimal cells decreasing vessel lumen space) and 
gradual occlusion of the graft. These pre-clinical and clinical results failed to gain the 
enthusiasm for adoption of these devices, therefore these devices are no longer used 
clinically.    
 The PAS-Port (Cardica Inc, Redwood City, CA) is the only commercially 
available proximal anastomosis system that is currently distributed in both Europe and 
the US (Figure 9). Unlike aforementioned devices, this novel device integrates the action 
of the aortotomy and deployment of the connector into a single tool. After loading the 
graft vessel onto the deployment tool, the tool is placed onto the target location and the 
surgeon rotates a knob on the tail-end of the tool to complete the anastomosis. In the 
pivotal EPIC trial, 220-patients requiring CABG with at least 2 vein grafts randomly 
received one graft with the PAS-Port device, and the other with a hand-sewn suture 
method. Results showed an 80.3% 9-month graft patency (state of being unblocked) 
versus 82.0% for hand-sewn. Similar freedom from major adverse cardiac events at 9-
Figure 9: Images of the PAS-Port proximal aortic connector. A) Integrated deployment and aortotomy 
tool, B) Loaded vessel being deployed onto the proximal aorta, C) PAS-Port connector after deployment 
onto the aortic wall showing compression of the vessel wall without penetration (Dohmen et al., 2011). 
14 
 
months was demonstrated between the two methods. However, the PAS-Port system was 
associated with a statistically significant, 4.6 ± 3.9 minute reduction in anastomotic time  
from the overall 7.7 ± 2.9 minutes required to complete conventional hand-sewn 
anastomosis(Puskas et al., 2009). Promising mid- to long-term results were also 
demonstrated in Japan (Kai et al., 2009) and Europe (Gummert et al., 2006). 
Technological innovations of the PAS-Port system include: 1) Integrated aortotomy and 
deployment tool, 2) Reduced non-biologic material exposure inside the vessel lumen, 3) 
Utilization of 316L stainless-steel material in replacement of nitinol. These 
characteristics may have contributed to the greater clinical results of PAS-Port system 
compared to preceding devices.  
 The second category of sutureless anastomotic devices are intended for distal 
anastomosis. Some of the more promising distal anastomotic devices are the Converge 
Coronary Anastomosis Coupler (Converge Medical Inc., Sunnyvale, CA) and the Cardica 
C-Port (Cardica Inc., Redwood City, CA). The Converge device is a two-piece coupler 
made of nitinol that clamps the vessels being anastomosed together (Figure 10). The graft 
vessel is placed between the two frames, which is loaded into a dedicated deployment 
Figure 10: Images of the Converge Coronary Anastomosis Coupler and the Cardica C-port anastomosis 
devices. A) Converge Coronary Anastomosis Coupler attached to an artery showing angled anastomosis 
through attachment of two coupled connectors (Boening et al., 2005), B) Cardica C-port anastomosis 
device showing angled anastomosis through stapling in a interrupted suture manner (P. Tozzi, 2007). 
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tool for insertion into the target artery at a 30° take-off angle. Loading of the coupler has 
been reported to be cumbersome and anastomosis leak has been common (Boening et al., 
2005). The C-port is an anastomosis device that deposits stainless steel staples to form an 
end-to-side anastomosis similar to an interrupted suture technique (Figure 10). In a 
single-center study, the anastomotic patency of the Cardica C-Port was compared to the 
hand-sew anastomosis. One-year patency rates between the two techniques showed no 
statistically discernible differences, and the incidence of complications was comparable 
to the hand-sewn anastomosis (Verberkmoes et al., 2013). The C-port is particularly 
promising because it creates an angled anastomosis, has similar non-intimal surface as a 
sutured anastomosis thereby requiring no anticoagulation therapy, and is capable of 
creating a side-to-end anastomosis in very small (1mm) diameter vessels (P. Tozzi, 
2007).  
 One of the most promising sutureless devices that addresses the limitations of 
vascular injury and foreign-body blood exposure is the Vascular Join (Idee & Sviluppo 
LLC, Bologna, Italy). The Vascular Join consists of two metallic rings that are fixed to 
Figure 11: Photograph showing the end-to-side version of the Vascular Join anastomosis 
device. End of a synthetic graft is fastened to the prosthesis and a saddle element is fastened on 




the exterior of either a biologic or synthetic graft (Figure 11). There are various sized 
elements accommodating 3 to 12 mm diameter grafts, but there are no restrictions in 
respect to vessel size. For end-to-side anastomosis, a saddle element is attached to the 
exterior of the desired side vessel by hooks that only penetrate the vessel wall without 
full-thickness penetration. After creation of an elliptical hole with a dedicated rotary 
blade, the graft with a pre-mounted ring is inserted to create the anastomosis. The device 
provides reproducible anastomosis with biologic and synthetic grafts with the advantages 
of zero foreign-body exposure to blood, angled geometry, and may be adapted to any size 
graft regardless of graft diameter and thickness. Clinical results for the end-to-end 
version of the Vascular Join showed 100% patency, immediate hemostasis, adequate 
blood flow and no instances of technical failure (Ferrari, Tozzi, & von Segesser, 2007). 
Long-term and end-to-side clinical studies are needed in order for this device to gain 
wide clinical acceptance.  
 All of the aforementioned devices, except the Vascular Join, are limited to 
applications of attaching small biologic vessels to either the ascending or descending 
aorta. None of these devices were designed for LVAD outflow grafts anastomosis, hence 
have not been tested in relevant models consisting of end-to-side anastomosis to a large 
aortotomy (>5 mm diameter) under turbulent and high pressures common to the 
ascending aorta. There are currently no commercially-available devices or scientific 
reports of sutureless anastomotic devices for LVAD outflow grafts, providing an 
opportunity for the development of innovative technologies to facilitate anastomosis of 





E. Surgical Adhesives 
 Surgical adhesives are a promising and growing area for development due to 
many potential clinical applications. Currently, octyl cyanoacrylate (Dermabond) is in 
use clinically to replace sutures for incisional or laceration closure (Bruns & 
Worthington, 2000). Other adhesives, such as fibrin sealants (e.g. EVICEL, TISSEAL), 
are clinically approved as an adjunct to standard sutures for hemostasis. Fibrin adhesives 
have shown to be highly effective in preventing leaks in conjunction with sutures for 
vessel-to-vessel anastomosis, as well as synthetic graft-to-vessel anastomosis (Saha et al., 
2012). In the application of wound closure, adhesives over the advantage of fast 
application, less traumatic closure, and the ability for application within difficult working 
environments.  
 Many hemostatic adhesives have been developed based on fibrin, collagen, 
cyanoacrylate (Hee Park et al., 2003; Szanka, Szanka, Şen, Nugay, & Kennedy, 2015), 
polyethylene glycol (Marc et al., 2000), albumin-glutaraldehyde (Küçükaksu, Akgül, 
Çağli, & Taşdemir, 2000; Mitrev, Belostotskii, & Hristov, 2007), or gelatin-resorcinal-
formaldehyde (Perrin et al., 2009). Other adhesives have drawn inspiration from nature, 
such as citrate-based mussel-inspired adhesive (Mitrev et al., 2007), and poly(glycerol 
sebacate acrylate)-based gecko-inspired adhesive (Mahdavi et al., 2008). Requirements of 
an ideal hemostatic surgical adhesive is that it must be easy to use, safe, polymerize in a 
wet environment, and have strong adhesion properties. Development of a strong 
hemostatic adhesive with these properties has the potential of replacing sutures.  
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 Several studies have attempted replacement of sutures with available hemostatic 
adhesives. Fibrin- and cyanoacrylate-based adhesives has been used to complete 
microvascular anastomosis (Carton, Heifetz, & Kessler, 1962; Carton, Kessler, 
Seidenberg, & Hurwitt, 1960; Carton, Kessler, Seidenberg, & Hurwitt, 1961; Ikossi‐
O'Connor, Ambrus, & Rao, 1983; Kim et al., 2004). However, fibrin adhesives are 
inherently weak adhesives and has not been reported to be used alone in high pressure 
arterial applications. Inadvertent entrance of both fibrin and cyanoacrylate may risk 
thrombus (blood clot) formation (Ang, Tan, Tan, Ng, & Song, 2001; LeMaire et al., 
2005; Middleton, Matthews, & Chiasson, 1991). Although cyanoacrylate-based adhesives 
have strong adhesive properties, they have been associated with anyeursmal dilatation 
(Carton et al., 1961) and tissue necrosis (Takenaka, Esato, Ohara, & Zempo, 1992). 
Recently developed adhesives have had promising results in repairing of high-pressure 
cardiovascular defects. One of the most promising adhesives is a hydrophobic light 
activated adhesive that demonstrated capability of closing 3 to 4 mm carotid artery 
defects and 2 mm full-thickness defects of the left ventricle in combination with a patch 
(Lang et al., 2014). Although this adhesive has shown comparable adhesive strength with 
cyanoacrylate adhesives, without the toxic effects, long-term studies are required for 
clinical approval.  
 A separate strategy that has been employed for replacing sutured anastomoses is a 
hybrid approach combining surgical adhesives with a mechanical coupling. Buijsrogge et 
al. reported a technique for end-to-side anastomosis using a extraluminal stainless steel 
frame with 4 downward facing hooks (Figure 12) (Buijsrogge et al., 2002). The device is 
inserted into the target vessel by inserting each hook element, then octyl-cyanoacrylate 
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adhesive is applied to consolidate the connection. Limitations of the device include a 
critical incision length, high external ring frame that can lead to kinking, and the adhesive 
used is only approved for external use (P. Tozzi, 2007). Other hybrid approaches have 
combined cuff systems with an adhesive, but all reports were limited to small vessels or 
low-pressure venous applications (Galvao, Bacchella, & Machado, 2007; Sacak, Tosun, 
Egemen, Sakiz, & Ugurlu, 2015).   
 
Figure 12: Drawing showing a hybrid mechanical and adhesive anastomosis device. Stainless steel ring 
has 4 hooks extended axially with thickening at the end that are elastic and can be bent for insertion. 
Vessel connection is consolidated by cyanoacrylate adhesive (P. Tozzi, 2007). 
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F. Device Design for LVAD Outflow Graft Anastomosis Device (GrAD) 
 The standard running suture technique is the preferred method for LVAD outflow 
graft anastomosis. However, this technique may be time-consuming, difficult to perform 
in constrained surgical spaces, and requires clamping of the aorta. Further, the 
progression of LVAD implantation surgery toward less-invasive and off-pump 
procedures increases the technical difficulty of completing standard hand-sewn LVAD 
outflow graft anastomosis due to uncompensated aortic flow dynamics and smaller 
surgical spaces.  These limitations of the standard sutured anastomosis motivates the 
development of a novel method for sutureless LVAD outflow graft anastomosis.  
 
1. Design Requirements for a LVAD Outflow GrAD 
 
 The general design criteria for an LVAD outflow graft anastomosis device 
(GrAD) are listed in Table 1. Any foreign material in the blood stream will likely trigger 
an inflammatory response (Anderson, Rodriguez, & Chang, 2008) and increase vessel 
wall stress (Scheltes, Heikens, Pistecky, van Andel, & Borst, 2000). Additionally, foreign 
materials elicit intimal hyperplasia leading to gradual decrease of effective luminal area 
Physiologic Design Requirements Mechanical Design Requirements
Minimal foreign-body non-intimal surface area Adaptable to range of graft diameters
Minimal tissue trauma Adaptable to range of wall thicknesses
Minimal alteration of native tissue compliance Attachable/detachable
Smooth profiles complementing intimal wall Easily deformable and elastic
Angled conformation Easily deployable  in small spaces
Clampless Recovery mode for device failure
Economical 




for blood to flow. Tissue trauma, which may be caused by suture or pin vessel wall 
penetration, is another source contributing to triggering an inflammatory response and 
intimal hyperplasia (Kornowski et al., 1998). In principle, a device with zero foreign-
body non-intimal surface exposure and tissue trauma is desirable to minimize 
inflammatory response, increase in wall stress, and intimal hyperplasia. 
Minimal alteration of the native compliance at the anastomosis, smooth profiles of 
the device to the intimal wall, and angled conformation minimize the negative effects of 
the device on vessel wall and blood flow properties. Sutured anastomoses are often 
associated with changes in vessel compliance observed through increased wall rigidity 
and alteration of elastic modulus at the anastomotic site (N. Baumgartner, Dobrin, 
Morasch, Dong, & Mrkvicka, 1996). There may also be a reduction in luminal area 
observed at the sutured anastomoses, which has been shown to reduce further during 
systole (Figure 13) or as blood pressure increases (Tozzi et al., 2000a, 2000b). Abrupt 
profiles of devices to the intimal wall may disrupt the natural wall shear stress patterns, 
which is associated with thrombus formation and intimal hyperplasia (Fillinger et al., 
1990; Ojha, 1994). Studies have demonstrated that anastomosis angle affects blood flow. 
The ideal anastomosis angle should be 30° to 45° (P. Tozzi, 2007). Anastomosis angles >  
60° demonstrate reductions in expected flow and creation of blood stagnancy areas (Leva 
& Engström, 2003; Zhang, Moskovitz, Piscatelli, Longaker, & Siebert, 1995). Therefore, 
highly compliant, smooth profiled, and angled anastomosis may reduce the disposition 
for the development of myiointimal hyperplasia and thrombus formation, as well as 
minimize the alteration of native vessel and blood flow properties at the anastomosis. 
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Clamping of the aorta creates an area of blood stagnancy such that an aortotomy 
can be created without the risk of hemorrhage (major loss of blood). Aortic clamping 
increases the risk of neurological complications (Zamvar et al., 2002) and aortic 
dissections (Stanger et al., 2002). For CABG procedures, clampless and off-pump 
procedures demonstrated lower mortality and stroke rates (Borgermann et al., 2012). A 
device allowing clampless anastomosis could similarly reduce the risk for any neurologic 
or aortic complications due to LVAD outflow graft anastomosis.  
An LVAD outflow GrAD should be adaptable to a wide range of graft diameters 
and aortic wall thicknesses. LVAD outflow graft diameter range from 10 mm to 20 mm, 
varying between LVAD types. Aortic wall thicknesses may range from 2 mm to 4 mm 
based on sex, race, and age shown in Table 2.  Wall thickness variability arises with 
elderly HF patients with calcified aortas that is shown to be associated with aortic wall 
thicknesses > 4 mm (Jang et al., 2012). To allow anastomosis of all LVAD outflow grafts 
to any patient, the GrAD should accommodate all graft diameters and adapt to any aortic 
wall thicknesses. LVAD outflow graft lengths are tapered to each patient by positioning 
the graft in its desired location and cutting off any unnecessary length in order to reduce 
Figure 13: Diagram showing systolic movement of vessel edges at the anastomosis due to 
sutured anastomosis. Schematic shows the reduction in cross-section lumen at systole or higher 
pressure (P. Tozzi, 2007). 
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the risk for graft kinking due to superfluous graft length in the constrained thoracic 
cavity. Some LVAD systems require the inflow end of the graft to be secured prior to 
completion of the outflow anastomosis, limiting the surgeon to a single free-end of graft. 
An attachable anastomosis system would allow surgeons to appropriately size grafts to 
patients then attach the anastomosis system to the free-end. An easily deformable and 
elastic device are important characteristics for development of an efficient deployment 
mechanism for the device, allowing it to remain undamaged when collapsed into a 
deployment catheter or sheath. An easy deployment mechanism is especially critical in 
less-invasive procedures where surgical windows are confined. A method for safe 
recovery of the anastomosis in the case of device failure is also of critical importance 




Table 2: Average and maximum wall thicknesses of ascending aorta. Large variability in wall 
thicknesses is shown based on sex, race, and age (Li et al., 2004). 
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2. Design Considerations for LVAD Outflow GrAD 
 There are three main design considerations for the development of a LVAD 
outflow GrAD: 
 1) Graft-to-vessel connection 
 2) Materials  
 3) Anastomosis biomechanical properties 
 
3. Graft-to-Vessel Connection 
There are four main mechanisms for connecting a sutureless device with either a 
graft or vessel: Pins, wall eversion, wall compression, and adhesion. Pins penetrate 
through the wall from either the inner lumen to the outside or from the opposite direction. 
If the pins push from the inside to the outside it allows the device to push outward 
radially reducing the risk of hemorrhage and generation of a dissection. If pins push from 
the outside to the inside the opposite occurs and there is an increased risk for hemorrhage 
and generation of dissection.  
Wall eversion is restricted to the tubular member with a free-end and typically 
employs an anvil to achieve eversion. This technique has larger implications for vessel-
to-vessel anastomosis, because it permits intima-to-intima contact. However, the main 
limitation of wall eversion is potential damage to the tissue itself as it is being everted, 
which is not a factor since the tubular member with a free-end being anastomosed would 
be a synthetic graft.  
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Wall compression is the most non-traumatic for the vessel wall if the two surfaces 
creating the compression are designed to allow for nutrient perfusion to the vessel wall 
itself. The advantage of this approach is it can easily be attached and detached. The 
limitation of this connection type is that it provides limited strength that can be 
catastrophic if it were to disconnect. Design limitations of previous devices relying on 
wall compression for connection include the amount of foreign material exposed inside of 
the vessel lumen. Coronary stents have demonstrated that large amounts of foreign 
material inside of vessel lumens results in intimal hyperplasia and re-stenosis (Lal et al., 
2003). Another design limitation of previous wall compression devices is the strict design 
constraints for wall-thickness due to a single-body component participating in the 
compression.  
Adhesive connection for anastomotic applications has been discussed earlier. 
Adhesives offer the advantage of minimal foreign-body exposure to the inner lumen. The 
main limitation of current hemostatic adhesives is that they have inadequate adhesive 
strength to connect tubular members alone or have toxic and/or thrombogenic properties 
in vascular applications. 
 
4. Materials 
Critical to any material implanted in the human body is that the material can 
interface with tissues without causing unacceptable harm to the body. Second, the 
material must have necessary material properties to accomplish and sustain their function 
for its intended implantation duration. For LVAD outflow graft anastomosis, materials 
must be capable of sustaining attachment to the continuously moving aorta for up to 8 
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years--the longest duration a LVAD has been implanted. Further, materials may contact 
blood flow exposing them to turbulent pressure and flow. Therefore, a LVAD outflow 
GrAD must ensure attachment in a dynamic environment to enable LVAD flow to the 
aorta, while having minimal impact on the major role of the aorta to dampen pulse 
pressures and provide blood to the body.  
Materials that have been used for cardiovascular applications include shape-
memory alloys and polymer textiles. Nitinol is one of the most commonly used metals for 
fabrication of sutureless anastomosis devices in the form of connectors, anvils, and self-
closing sutures. Alternative metals that are also commonly used are stainless steel and 
cobalt-chromium alloy. These metals allow for fabrication of devices that can be 
collapsed into deployment tools for introduction through limited surgical spaces and 
deployment into their desired location. With limited blood exposure area, these bare-
metals have served well as anastomosis connectors. Intimal hyperplasia is the main cause 
of long-term failure associated with metallic devices as tissue proliferation leads to 
narrowing and obstruction. Trauma to the nearby tissue from metallic devices leading to 
intimal hyperplasia is due to physical irritation rather than chemically induced from 
corrosion of the metal (Williams, 2008), suggesting that these metals have adequate 
corrosion resistance. When using shape-memory alloys, designs should minimize the 
surface area of the material exposed to blood and potential for vessel trauma (e.g. vessel 
penetration, friction rubbing) to reduce the extent of intimal hyperplasia. 
Expanded polytetrafluoroethylene (ePTFE) and polyethylene terephthalate (PET, 
Dacron) compose the majority of polymers used for fabrication of vascular grafts and 
sewing rings. These polymers react similarly within the human body (Mueller & 
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Dasbach, 1994). Upon implantation, thrombus is formed within the pores and cellular 
infiltration occurs. Then cellular proliferation via fibroblasts provides tissue in-growth 
with connective tissue. For inner lumen surfaces of vascular grafts, intimal hyperplasia 
leads to deposition of cell layers lining the inner surface of the graft. Synthetic grafts are 
recognized to function reasonably in large diameter and high flow applications, where 
narrowing due to intimal hyperplasia has a smaller impact on overall flow and rarely 
leads to obstruction. The few reported cases of LVAD outflow graft obstruction were due 
to factors extrinsic to the graft (Bergmann, Kottenberg-Assenmacher, & Peters, 2007; 
Frogel, Vodur, & Horak, 2008; Kaplon et al., 2001; Weitzel, Puskas, Cleveland, Levi, & 
Seres, 2009).  There are reports of synthetic graft degradation after 15 years of implant 
(Shiiya, Kunihara, Matsuzaki, & Sugiki, 2006; Van Damme, Deprez, Creemers, & Limet, 
2005), however, the duration for graft degradation far exceeds that of current LVAD 
implantation durations. Therefore, ePTFE and PET should be acceptable graft materials 
for fabrication of a GrAD. 
 
5. Biomechanical Properties  
The natural biologic properties of vessels are altered by anastomosis, such as 
vessel compliance. Generally, more compliant anastomosis devices impart less influence 
on the natural elastic properties of the vessel which may reduce changes in wall stress 
and risk for intimal hyperplasia. It can be speculated that sutureless anastomosis devices 
fabricated from shape-memory alloys and elastic polymers will be more compliant that 
running suture anastomosis since these materials are more elastic than polypropylene 
suture. Alterations in blood flow is another concern as anastomosis angle and material 
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profiles in the blood stream may affect the flow patterns and wall shear stress at the 
anastomosis. Therefore, a highly compliant and 30° to 45° angle anastomosis, and 
smooth profiles of foreign bodies conforming to the luminal vessel wall may reduce 
potential risk of complications inherent to alterations of biomechanical properties of the 
native aorta.  Patched or cuffed anastomoses have demonstrated better patency (Brumby, 
Petrucco, Walsh, & Bond, 1992) and lower peak wall shear stress (Harris, 1999; Walsh, 
Kavanagh, O'brien, Grace, & McGloughlin, 2003). Subsequently, a sutureless LVAD 
outflow GrAD should promote the native biomechanical properties of the blood vessels 















A. Study Design 
 
The objective of this study was to develop a LVAD outflow GrAD to facilitate 
anastomosis to the ascending aorta. To demonstrate proof-of-concept, the following aims 
were proposed: 
1) Complete fabrication of a device enabling sutureless anastomosis of LVAD 
outflow graft to the ascending aorta 
2) Complete feasibility testing of candidate prototype GrAD to demonstrate 
secure connection under static and dynamic pressures 
3) Complete feasibility testing of candidate prototype GrAD to demonstrate 
comparable attachment strength as standard sutured anastomosis technique 




To successfully complete the proposed aims, three studies were completed: 1) static 
pressure testing (n=3), 2) dynamic mock loop pressure testing (n=3), and 3) paired pull-
out force testing to compare GrAD to sutured anastomosis (n=3) (Figure 14). 
The prototype GrAD comprised of an attachable nitinol connector, polymer felt 
flanged cuff, and adhesive (Figure 15). Prototypes of the components were fabricated and 
tested experimentally to investigate smooth conformation in plastic models and bovine 
aorta specimens. Preliminary testing of several adhesives was completed to assess 
capability of adhering the device to aortic tissue while maintaining connection without 
significant fluid leakage. The anastomosis device was tested in static pressure and 
dynamic mock loop pressure models using harvested bovine descending aorta and de-
ionized (DI) water. Paired mechanical pull-out experiments for device completed 
A B 
C D 
Figure 15: Photographs of various views of the prototype LVAD outflow graft anastomosis device 
(GrAD) consisting of a nitinol connector fastened to a 15 mm vascular graft and felt flanged cuff: 
A) Side-view, B) Top-view, C) Bottom-view, D) Top-view inside lumen of graft 
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anastomosis and hand-sewn suture anastomosis attached to bovine descending aorta were 
performed to quantify peak tensile force measured in Newtons (N) before failure. 
 
B. Prototype Design Development 
Literature, patent application, and patent reviews were conducted to evaluate intellectual 
property of other potential competing devices developed for sutureless and end-to-side 
anastomosis. Based on the literature and patent review, and design considerations for a 
sutureless LVAD outflow GrAD, design specifications were established, as shown in 
Table 1. The design of combining a nitinol connector, polymer felt flanged cuff, and 
adhesive was selected for further development. Curvature of the CADs were dimensioned 
based on human adult ascending aorta dimensions (Rylski, Desjardins, Moser, Bavaria, & 
Milewski, 2014).  
 
C. Nitinol Connector Fabrication 
 In order to fabricate each nitinol connector, metal frames were used to mount the 
wire into its desired shape, annealed in a high-temperature oven, and quenched in a cold-
water bath. Flat and curved nitinol connectors were fabricated using several different 
gauges of nitinol wire. The various nitinol connector types were assessed for strength and 







Figure 16: Photographs of preliminary fit studies of the nitinol connector within silicone tubing and 
bovine descending aorta specimens. A) Curved nitinol connector within silicone tubing showing curvature 
due to forces exerted by the tubing, B) Struts of a flat nitinol connector protruding out of the aorta due to 
rigidity of thick wire gages, C) Poor conformation of a flat nitinol connector to the inner lumen aortic wall 
that have the potential for causing complications 
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1. Frame Construction 
For flat nitinol connector frames, 3.175 mm thick flat stainless steel plates were 
cut into 31.175 mm x 31.175 mm squares. For curved nitinol connector frames, 31.75 
mm outer diameter copper slip couplings were used. Template drawings directing 
placement of screws for molding the nitinol shape were created using SOLIDWORKS 
2015 and attached to the frames. With a mill, 2.0 mm titanium drill bit was used to bore 
holes for setting main shape of the connector and a 2.4 mm titanium drill bit was used for 
B C 
A 
Figure 17: Photographs of the nitinol connector frame fabrication. A) Mill used for boring holes 
according to template mounted onto copper slip coupling, B) Copper slip coupling used to create curved 
nitinol connectors, C) Steel plate used to create flat nitinol connectors. 
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anchoring the nitinol wire. Each hole was threaded using a 2-56 and 4-40 tap and die set 
for the 2.0 and 2.4 mm bored holes, respectively. Stainless steel screws corresponding to 
the threaded hole size were inserted into the frames. Photos of the completed frames are 
shown in Figure 17. 
 
2. Shape Setting Nitinol 
Super elastic temper, light oxide nitinol round wire (0.76, 0.50, 0.40, 0.36, 0.23, 
and 0.18 mm gauge) was used to create the nitinol connectors. The end of the nitinol wire 
was secured to the frames using binder clips and reinforced by wrapping the wire several 
times around the 4-40 anchoring screws. Then the wire was wrapped tightly around each 
of the 2-56 screws to form the desired shape and each screw was tightened to ensure that 
the wire was held securely in tension. The free-end of the wire was anchored by wrapping 
the wire around the anchoring screw. Excess wire was removed and the remaining end 
was secured to the frame with a second binder clip.  
 Nitinol frames were placed in a Thermolyne Benchtop Muffle Furnace 
(ThermoScientific, Waltham, MA) pre-heated to 530°C for 9 minutes. Frames were 
removed from the furnace and quenched immediately in a room temperature bath of DI 
Figure 18: Photograph of candidate prototype nitinol connectors of various wire gauges, curved/flat 




water. After cooling, the frames were air-dried. Each screw was loosened and the wire 
was carefully removed from the frames. Excess wire was removed and the loose ends 
were fastened together using 2-0 Black Braided silk suture (Ethicon, Somerville, NJ). 
Figure 18 shows various candidate nitinol connectors that were assessed for fitting. 
A single end of a 15 mm Gelweave Gelatin Impregnated Woven Vascular 
Prosthesis vascular graft (Vascutek Ltd, Glasgow, UK) was cut at a 45° angle. Each 
nitinol connector was fastened to the graft with 7 radially tied 2-0 Ethibond Excel 
polyester suture (Ethicon, Somerville, NJ). Combined graft and nitinol connector were 
inserted into 19.05 mm inner diameter Zygon silicone tube (Saint-Gobain North America, 
Malvern, PA) through a 15.0 x 21.2 mm axes elliptical hole. Combined graft and 
connector were assessed for ease of insertion and smooth conformation to the inner 
lumen. Select nitinol connector designs were further assessed using bovine descending 
aorta specimens for identical assessment parameters. Based on these preliminary 
assessments, additional 0.36 mm gauge curved nitinol connectors were fabricated for 
further experimentation (Figure 19).  
Figure 19: Photographs of 0.36 mm gauge nitinol connector providing smooth conformation to the luminal 
wall of a bovine descending aorta specimen. 
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D. Felt Flanged Cuff Fabrication 
 Medical-grade polymer felt was cut and hand-sewn using 2-0 Ethibond Excel 
polyester suture (Ethicon, Somerville, NJ) to construct the flanged cuff structure as 
shown in Figure 20. Three coats of GE Silicone II (General Electric, Fairfield, CT) were 
applied to the exterior of each cuff, allowing each coat to cure for at least 30 minutes 
before re-application. After application of the final coat, they were allowed to dry for 24 
hours before initiating static and dynamic pressure testing. 
E. Bovine Aorta Specimens 
 Descending aorta specimens were excised from adult male jersey calves within 6 
hours of euthanasia. Specimens were removed carefully to maintain as much length of 
any branching arteries. Each vessel was immediately submerged in 3°C Belzer UW Cold 




Figure 20: Photographs of prototype felt flanged cuff. A) Sewn flanged cuff without silicone coating, 
B) Flanged cuff with 3 coats of silicone. 
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F. Static and Dynamic Pressure Testing 
 Cyanoacrylate, octylacrylate, and fibrin/thrombin adhesives were tested for 
adequate attachment strength of the GrAD to the bovine descending aorta specimens. The 
selected adhesive for attachment was cyanoacrylate. After thawing bovine descending 
aorta specimens, any branching arteries were tied off using 3-0 silk ties. If there was 
inadequate length to tie off branching arteries, 5-0 Prolene suture was used to cinch the 
hole shut and a drop of cyanoacrylate adhesive was applied for sealing. Tubing 
connectors were inserted into each end of the aorta specimen and secured using a 
combination of 2-0 silk ties and zip ties. Elliptical aortotomies were created in bovine 
descending aorta specimens (n=3) with major and minor mean axis ± standard deviation 
lengths of 10.5 ± 0.4 mm and 15.7 ± 0.9 mm, respectively. Combined graft and nitinol 
connectors were inserted through the aortotomy. Using opposition by pulling the free-end 
of the graft, the flanged cuff was slid down the exterior of the graft to interface snug with 
the exterior of the aorta. .07 mL of cyanoacrylate adhesive was applied between the 
flanged cuff and vessel, and between the graft and flanged cuff. Each anastomosis was 
allowed to cure for 30 seconds before attaching the vessel to the static/dynamic mock 
loop in its natural forward flow orientation. A new nitinol connector and flanged cuff was 
used for each experimental set.  
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The experimental setup (mock loop model) used for static pressure testing is 
shown in Figure 21. For each vessel an internal pressure of 0, 50, 100, 150, and 200 
mmHg was applied and maintained at steady-steady ( ± 2mmHg) at each pressure step for 
30 seconds, and any fluid leakage from the anastomosis was collected in a basin placed 
underneath the vessel. Total fluid loss at each pressure step was measured using a 
graduated cylinder. Fluid leak rate was calculated using the following equation and 
converted to mL/min for reporting: 








 [𝐿𝑒𝑎𝑘 𝑅𝑎𝑡𝑒] 
Pressure was set using a pressure hand pump (Meriam Process Technologies, 
Cleveland, OH) connected to a SMART Manometer (Meriam Process Technologies, 
Cleveland, OH) and an air column compliance chamber via a three-way adapter. Internal 
Figure 21: Photograph showing experimental setup for static pressure testing. 
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pressure was measured using a Mikro-tip Pressure Transducer (Millar, Houston, TX) and 
continuously monitored with Labchart 8 (AD Instruments, Sydney, Australia).  
 
Dynamic pressure testing was completed using the mock flow loop model shown 
in Figure 22. The simulated test conditions and hemodynamic parameter requirements of 
each condition are shown in Table 3. The following hemodynamic measurements were 
continuously recorded for 30 seconds at a 400 Hz sampling rate using Labchart 8: 
1. Aortic Pressure (AoP) – mmHg 
2. Arterial Pressure (ArtP) – mmHg 
3. Aortic Flow (AoF) – L/min 
4. Ventricular Assist Device Flow (VADF) – L/min 
Fluid leakage from the anastomosis was collected during each data set and measured 
using a graduated cylinder. Mikro-tip Pressure Transducers were used to measure 
pressure and PXL Clamp-on Flowsensors (Transonic Systems Inc., Ithaca, NY) to 
measure flow. The mock ventricle was fitted with a single leaflet mechanical valve at the 
inlet and a trileaflet mechanical valve at the outlet with filling and ejection controlled 
using a customized pulse duplicator (LB Technology LLC, Louisville, KY). A Castaloy 
Normal Hypertension Heart Failure Partial Support
Artmean (mmHg) 90 - 110 > 120 < 90 80 - 100
ArtPsystolic  (mmHg) 110 - 130 > 140 < 100 100 - 120
ArtPdiastolic  (mmHg) 70 - 90 > 100 < 60 60-90
AoFmean (L/min) 4.5 - 5.0 4.5 - 5.0 3.0 - 4.0 4.0 - 5.0
VADFmean (L/min) 0.0 0.0 0.0 2.0 - 3.0
Table 3: Hemodynamic tuning parameters for each dynamic mock loop condition. 
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clamp (Thermo Fisher Scientific, Waltham, MA) was used to vary afterload resistance. 
An air-filled column chamber was used to vary compliance. For the LVAD support test 
condition, a HeartMate II (Thoratec Corp., Pleasanton, CA) was used. All hemodynamic 
data were signal conditioned using a custom data acquisition system (Koenig et al., 
2004). All pressure and flow transducers were pre- and post-calibrated using an 
established technique (Koenig et al., 2004).  
 
G. Pull-out Testing 
The experimental setup for mechanical pull-out testing is shown in Figure 23. 
Following completion of the static and dynamic pressure tests, an experienced cardiac 
surgeon anastomosed a 15 mm GelWeave graft in a running suture technique with 4-0 
Prolene suture onto the same aortic specimen used in static and dynamic pressure tests 
(note: same person performed all hand sutured anastomosis for all tests). For each vessel, 
Figure 22: Photo and block diagram showing experimental setup for dynamic mock loop pressure tests; 
Systemic vascular resistance (SVR); left ventricular assist device (LVAD). 
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a hand-sewn anastomosis was constructed on the opposite side of the previously attached 
anastomosis device. A 12.7 mm diameter round bar was passed through the vessel, which 
was then mounted to a 609.6 x 609.6 x 12.5 mm piece of slate. The graft from the 
anastomosis being tested was secured in-between two metal plates with sandpaper 
adhered to the contacting surfaces. #16 wire was passed through a bored hole through the 
plates to attach the graft to a HF-50 Force Gauge (M&A Instruments Inc., Arcadia, CA). 
A preload of 2.5 ± 0.5 N was applied before hand-pulling the gauge vertically upwards 
until failure and peak force was achieved and recorded. Each vessel and graft was 
photographed at the original site of the anastomosis. The hand-sewn anastomosis or 
device anastomosis was randomly selected to be tested first, but it was ensured that at 
least one from each group was tested first.  
Figure 23: Experimental setup for pull-out testing. 
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H. Analysis Methods 
The mean hemodynamic parameter values recorded during the dynamic pressure 
testing were calculated on a beat-to-beat basis using Labchart 8. Previously reported 
results for blood leakage rates under normal dynamic pressure (120/80 mmHg) associated 
with hand-sewn suture anastomoses (Sergeant, Kocharian, Patel, Pfefferkorn, & 
Matonick, 2016) were used for comparison. All statistical tests were performed using 
GraphPad Prism (GraphPad Software Inc., La Jolla, CA) and a 95% confidence level (p 
















A. Final Prototype Design 
  
Figure 24: Dimensions of the prototype nitinol connector used for experimentation. 
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 The dimensions for the nitinol connector and flanged cuff that were tested 
experimentally are shown in Figures 24-25. A curved 0.36 mm thick nitinol wire with 
intermittent spring elements was selected based on ease of collapsibility, smooth 
conformation to the luminal vessel wall, adequate rigidity to remain within the vessel, 
and capability to be fastened to a vascular graft. The addition of spring elements 
enhanced the collapsibility of the connector and provided a graft attachment point.  
 
B. Static Pressure Testing 
A summary of the leak rates for all static pressure steps are presented in Table 4. 
There was an increase in mean leak rate with increasing pressure for all device completed 
Figure 25: Dimensions of the prototype flanged cuff used for experimentation. 
45 
 
anastomoses. All leaks were categorized as drips. Notably, a consistently larger leak rate 
was reported in vessel #2 at all pressure steps (Figure 26). 
 
 


























Figure 26: Leak rates for each vessel during static pressure tests. Vessel 2 consistently showed greater leak 





0 0.00 ± 0.00
50 5.6 ± 7.1
100 11.9 ± 11.4
150 22.7 ± 20.7
200 43.6 ± 23.4
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C. Dynamic Pressure Testing 
 Each of the dynamic pressure test conditions met the aforementioned 
hemodynamic requirements for ArtP, AoF, and VADF. Pressure trends consistent with 
other mock loop studies (Bartoli et al., 2010; Giridharan et al., 2015) were observed in 
ArtPmean, PAoPmean, AoF, and VADF between conditions (Table 5, Figure 27):  
 1) Increased mean pressures from normal to hypertension 
 2) Decreased mean pressures and AoF from normal to heart failure 
 3) Increased mean pressures and flows from heart failure to LVAD support 
Sample pressure and flow waveforms for each dynamic pressure test condition are shown 
in Figure 28. 
 
Figure 27- Graphs comparing pressure and flows for each dynamic mock loop condition reflecting typical 
physiologic trends in hemodynamic parameters associated with each condition; arterial pressure (ArtP); 




Figure 28: Sample waveforms collected for normal, hypertension, heart failure, and LVAD support dynamic 










ArtPmean (mmHg) 100 ± 2 131 ± 1 79 ± 4 83 ± 7
ArtPsystolic  (mmHg) 121 ± 1 153 ± 2 94 ± 4 99 ± 6
ArtPdiastolic  (mmHg) 82 ± 2 111 ± 3 65 ± 2 67 ± 5
AoPmean  (mmHg) 112 ± 8 143 ± 10 86 ± 10 106 ± 9
AoPsystolic  (mmHg) 154 ± 18 187 ± 24 127 ± 24 160 ± 26
AoPdiastolic  (mmHg) 64 ± 7 84 ± 13 44 ± 8 55 ± 18
AoFmean (L/min) 4.79 ± 0.14 4.67 ± 0.11 3.65 ± 0.19 4.09 ± 0.09
VADFmean (L/min) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 2.49 ± 0.26
Table 5: Mean ± standard deviations of hemodynamic parameter measurements calculated on a beat-to-
beat basis for dynamic mock loop tests; arterial pressure (ArtP); aortic pressure (AoP); aortic flow (AoF); 
ventricular assist device flow (VADF); left ventricular assist device (LVAD) 
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The leak rates recorded for dynamic pressure tests are listed in Table 6, and the 
leak rates for the static and dynamic pressure tests are shown in Figure 29. Although a 
noticeable positive correlation was observed between mean leak rate and mean pressures, 
no statistically discernible differences were observed. The leak rates for normal mock 
flow loop condition and literature reported leak rates for sutured anastomosis are shown 
in Figure 30. A one-way ANOVA demonstrated a significant difference in leak rate 
between the GrAD and sutured anastomosis (p ≤ 0.05) was observed. A Tukey 
comparison test showed significant differences in leak rates between the GrAD and 
Prolene 2, as well e-PTFE sutures (Table 7, Figure 30). No differences in leak rate 
between the GrAD and other sutures were statistically discernible. All leaks were 
categorized as drips.  
 
Table 6: Mean ± standard deviation leak rates for dynamic mock loop pressure tests; 






Normal 22.1 ± 9.3
Hypertension 23.1 ± 10.1
Heart Failure 16.4 ± 6.4





Suture Size Needle Type N:S Ratio Suture Material
Sergeant et al. Study Sutures
Hemo-Seal Prolene (HS) 5-0 C-1 1.84:1 Monofilament polypropylene
Prolene 1 (PR1) 5-0 C-1 2.41:1 Monofilament polypropylene
Prolene 2 (PR2) 5-0 C-1 2.06:1 Monofilament polypropylene
e-PTFE (PTFE) CV-6 TTc-13 1.4:1 Monofilament e-PTFE
Additional Graft Sutures
Prolene 3 3-0 SH 2.6:1 Monofilament polypropylene
Prolene 4 4-0 SH 3.47:1 Monofilament polypropylene
Prolene 5 5-0 SH 5.2:1 Monofilament polypropylene
Figure 29: Leak rates for static and dynamic pressure tests; left ventricular assist device (LVAD). 
Table 7: Specifications for typical suture types used for anastomosis; needle:suture diameter ratio (N:S 




D. Pull-Out Testing 
 A comparison of peak pull-out forces for the GrAD and suture anastomosis is 
shown in Figure 31. The sutured anastomosis had a 19.9 N higher mean peak pull-out 
force than the device anastomosis, but paired t-test showed no significant difference in 
means.  
Sample photos of the anastomosis device and aorta at the site of the anastomosis 
after pull-out testing are shown in Figure 32. All modes of failure for the GrAD appeared 
to be due to delamination of the adventitia (outermost layer of vessel tissue) based on the 
confluent layer of tissue observed on the flange face attached to the aorta. This was 
further supported by the discernably continuous difference in tissue color and depth on 
Figure 30: Graph comparing mean leak rate from graft anastomosis device (GrAD) and literature reported 
leak rate of Hemo-Seal (HS), Prolene (PR 1, PR 2), and expanded-polytetrafluoroethylene (PTFE) sutures. 
Asterisks show significant differences between GrAD and PR1 and PTFE (p < .05). 
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the aorta at the site of the failed anastomoses. No signs of damage were observed in the 
nitinol connector or flanged cuff for all samples.  
Figure 32: Peak pull-out force for graft anastomosis device (GrAD) 
and sutured anastomosis. 
A B 
Figure 31: Photographs of the graft anastomosis device (GrAD) after pull-out testing with no indications 
of device damage. A) The debonded device with an observable layer of adventitial tissue on the flanged 
cuff, 2) Bovine descending aorta after delamination of a portion of the adventitial tissue by the device. 
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Sample photos of the suture and aorta at the site of the anastomosis are shown in 
Figure 33. The mode of failure for two of the suture anastomoses was due to the tissue 
tearing propagating from the suture holes. This was supported by the slits observed at 
every suture hole on the aorta and the remaining tissue within the intact sutures. For 
Vessel 2, the mode of failure appeared to be in part due to tissue tear propagation, as well 
as fracture of the suture. This was supported by the absence of slits propagating from a 
portion of the suture holes. Furthermore, a sliver of tissue remained where the suture was 
intact, but no tissue remnants were observed where the suture fractured (Figure 33).  
  
A B 
Figure 33: Photographs of the suture anastomosis after pull-out testing. A) Anastomosis site on the aorta 
















 In regards to static pressure and dynamic pressure testing, all GrADs remained 
securely attached throughout all physiological hemodynamic test conditions. All leak 
rates were classified as drips that may have clotted if whole blood had been used (instead 
of water). The majority of leaks were observed to originate from the vascular graft that 
was uncovered by the flanged cuff and from ineffectively closed branching vessels from 
the aorta. Leaking innate to the device originated from the attachment of the graft and 
flanged cuff. It is speculated that a poor seal was created where the cuff, graft, and 
aortotomy interfaced. Alternative adhesives or solutions for attaching the flanged cuff 
and graft material may mitigate or effectively seal this connection point from leaking.  
 Comparison of leak rates under normal physiologic pressure (120/80 mmHg) 
between the GrAD and sutures showed statistically significant lower leak rate by the 
device compared to Prolene 1 and PTFE suture, and no statistically discernible 
differences were observed in comparing Hemo-Seal Prolene and Prolene 2 (Table 07). 
Sergeant et al. evaluated needle-hole blood leakage of various suture types from an end-
to-end anastomosis of ePTFE grafts at normal physiologic pressures (120/80 mmHg) 
(Sergeant et al., 2016). Higher needle:suture (N:S) ratios were associated with higher leak 
rates; therefore, it can be speculated that leak rates of other common sutures for 
54 
 
anastomosis with larger N:S ratios (Prolene 3, Prolene 4, Prolene 5) may have resulted in 
significantly higher leak rates similar to Prolene 1. There were several differences in 
experimental design between the Seargent et al. study and the normal dynamic pressure 
test in this project, including: 1) an anticoagulated blood solution as opposed to DI water, 
2) non-porous ePTFE grafts were used rather than gelatin-impregnated porous PET. 
Anticoagulated blood has been previously shown to leak from a syringe tip at rate 5.5 
times slower than water (Elblbesy, 2014). The non-porous ePTFE graft did not contribute 
to the total leak rate, whereas leakage from the porous gelatin-impregnated grafts was 
included in the total leak rate in these experiments. The lower associated leak rate of 
blood and non-porous graft material would suggest that suture leak rates in the Sergeant 
el al. study should be less than the device. These variations may have contributed, in part, 
to the 11.6% reduction in mean leak rate of Hemo-Seal suture compared to the device, 
although it was demonstrated that the GrAD produced similar leak rates as conventional 
sutures used for anastomosis.  
In regards to peak pull-out strengths, no statistically significant differences were 
discerned between GrAD and sutured anastomosis. Based on the GrAD failure mode 
attributed to delamination of the adventitial layer of the aorta, pull-out strength is 
believed to be dependent on the strength of the bonds between aortic tissue layers 
suggesting that the bond strength provided by cyanoacrylate adhesive between the 
flanged cuff and aortic tissue is stronger than the bond strength between the layers of the 
aorta. Comparatively, pull-out strength for suture anastomosis is believed to be dependent 
on the strength of the suture and the strength of the aortic wall against an opening mode 




Sutureless connection to the aorta minimizes potential risk of tissue trauma 
inherent to the presence of non-absorbable sutures through the tissue. It may also reduce 
the time required to complete the anastomosis and be configured for a range of aortic 
thicknesses and graft diameters. Since this device employs a two component attachment 
method to compress the aortic wall, it is not limited by narrow range of aortic thickness 
specifications associated with the Symmetry and Pas-PORT devices. Up-scaling or 
down-scaling the connector dimensions to accommodate different graft diameters would 
simply require proportional scaling of the frames used to fabricate the rings. In GrAD 
design, an angled anastomosis is maintained by the flanged cuff which has been shown to 
promote superior blood flow dynamics and reduce the risk of clinical adverse events. 
 An important design consideration is the selection and/or development of a 
surgical adhesive. Acrylate-based adhesives, including cyanoacrylate, have not been 
approved for human internal use and have been reported to be toxic and thrombogenic. 
Fibrin glue adhesives, which are approved for human internal applications, were 
evaluated as a candidate adhesive for the device. However, we chose to use water (rather 
than whole blood) to demonstrate early feasibility, which did not allow clot formation 
and likely resulted in a higher leak rate. Fibrin sealant has been used to achieve 
hemostasis at the higher pressure levels in the arterial systems (B. Baumgartner, Draxler, 
& Lewis, 2016; N. Baumgartner et al., 1996; Detweiler, Detweiler, & Fenton, 1999),   
warranting further investigation of fibrin and other adhesives as an alternative solution. In 
this study, it was demonstrated that cyanoacrylate is capable of securely attaching LVAD 
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outflow grafts to the aorta, and is worth further consideration and investigation as a 
potential clinical sealant.  
 
A. Limitations 
To demonstrate proof-of-concept of device performance and early feasibility of 
device function, a small sample size (n=3) for each test was performed. Larger sample 
size based upon a power analysis will be required to demonstrate statistical significance, 
which will likely be performed once a design freeze has been achieved. A limitation 
associated with the static and dynamic leak testing was that in quantifying the leak rate, 
the fluid volume from the graft and branching vessels (not completely closed) were 
included in the overall leak rate calculation. For example, Vessel #2 was observed to be 
leaking in large part from the graft section that was not covered by the flanged cuff, 
which may be attributed to protein degradation of the gelatin that was impregnated into 
the porous graft. Vessels #1 and #3 were not observed to be leaking as profusely from the 
graft during static pressure tests.  A second limitation of the pressure experiments was the 
use of water rather than whole blood, which represented a lower viscosity as is seen in 
anticoagulated blood and a worst case for leak rate.  In future testing, the leak rate should 
be lower with the use of whole blood. A limitation associated with the pull-out tests was 
the apparatus constructed for testing. Since the force gauge was pulled vertically by hand, 
inconsistent directional tension may have been applied to each test sample. Second, the 
velocity that the force gauge was pulled may have varied for each test sample. These 
variables could be addressed if future pull-out experiments were conducted using a 
universal testing machine.  
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 Cryopreservation methodology of the bovine descending aorta specimens may 
have altered the natural mechanical and molecular properties compared to fresh harvested 
tissue. UW solution is a commonly used solution hypothermic storage of blood vessels to 
minimize cellular degeneration (Abrahamse, Dinant, Pfaffendorf, & Van Gulik, 2002). 
However, hypothermia and cryopreservation has been shown to induce cellular damage 
(Wille, de Groot, & Rauen, 2008). Previous studies comparing vessel mechanics of fresh 
and cryopreserved tissues have reported contradictory results on the effects of 
cryopreservation, although a majority have found no significant differences (Stemper et 
al., 2007). A recent study demonstrated that vessels maintained physiological mechanics 
after 3 months of cryopreservation (Stemper et al., 2007). All bovine descending aorta 
specimens used for experiments were stored at -80°C for 3 to 4 months before 
experiments using similar established methods for cryopreservation. There is still a 
potential that the hypothermic storage, tissue handling, and series of experiments could 
have altered the behavior of the tissue affecting the results of this project. Fresh aortic 
















The primary objective of this MEng thesis to develop a novel device that 
facilitates LVAD outflow graft anastomosis by demonstrating proof-of-concept and 
feasibility of prototype design. The preliminary data demonstrated feasibility as 
evidenced by secure connection to the aorta over a wide range of physiologic static and 
dynamic pressures, as well as leak rates and connection strength comparable to 
conventional hand-sutured anastomosis. Future developmental work should focus on (1) 
alternative adhesive exploration and (2) deployment tool. Since the nitinol connector and 
flanged cuff are collapsible, the components can be easily loaded into a deployment tool 
for device delivery.  A dedicated deployment tool would also allow for the device to be 
deployed in small surgical windows using less invasive surgical techniques. 
Three key characteristics of the prototype GrAD that may facilitate LVAD 
outflow graft anastomosis are: 1) sutureless connection to the aorta, 2) adaptable to 
various aortic thicknesses and graft diameters, and 3) 30-45 angled anastomosis. This 
novel device could provide an alternative method for LVAD outflow graft anastomosis 
that may be completed faster, more consistently, and with less dependence on surgical 
skill than conventional hand-suturing, thereby potentially allowing outflow anastomosis 
to be completed less-invasively. The device enables a sutureless, adaptable, and angled 
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anastomosis. Thereby, it has the potential of facilitating less-invasive LVAD 
implantation, faster implant time, and improving the reliability and reproducibility with 
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APPENDIX I: RAW AND ADDITIONAL DATA 
 
Table 8: Static pressure test raw leak rate data. 
  
Pressure (mmHg)
Leak Rate (mL/30s) Note Leak Rate (mL/30s) Note Leak Rate (mL/30s) Note
0 0 Drip 0 Drip 0 Drip
50 0.6 Drip 7.8 Drip 0 Drip
100 1.6 Drip 14 Drip (Graft) 2.2 Drip
150 3.8 Drip 26 Drip (Graft) 4.2 Drip
200 5.4 Drip 32 Drip (Graft) 28 Drip (graft)
Leak Rate (mL/30s)




Table 9: Dynamic pressure test leak rate raw data. 
 
  
Leak Rate (mL/30s) Note Leak Rate (mL/30s) Note Leak Rate (mL/30s) Note
Normal 5.6 Drip 17 Drip (graft) 10.5 Drip
Hypertension 5.7 Drip 18 Drip (graft) 11 Drip
Heart Failure 6.8 Drip 12.6 Drip (graft) 5.2 Drip
Partial VAD Support 7.9 Drip 11 Drip (graft) 5.7 Drip
Vessel 1 Vessel 2 Vessel 3
Dynamic Pressure Leak Rate Data
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Table 11: Pull-out force raw Data. 
 
  
Peak Pull-out Strength (N) 
  Device Suture 
1 63.43 53.43 
2 31.62 67.95 












APPENDIX II: STATISTICAL ANALYSIS 
 
 
A) Dynamic Pressure Leak Rate ANOVA 
 
Table Analyzed Data 1     
      
ANOVA summary      
  F 0.4194     
  P value 0.7441     
  P value summary ns     
  Are differences among means statistically significant? (P < 0.05) No   
  
  R square 0.1359     
      
Brown-Forsythe test      
  F (DFn, DFd) 0.4021 (3, 8)     
  P value 0.7555     
  P value summary ns     
  Significantly different standard deviations? (P < 0.05) No     
      
Bartlett's test      
  Bartlett's statistic (corrected)      
  P value      
  P value summary      
  Significantly different standard deviations? (P < 0.05)      
      
ANOVA table SS DF MS F (DFn, DFd) P value 
  Treatment (between columns) 117.0 3 39.01 F (3, 8) = 0.4194 P = 
0.7441 
  Residual (within columns) 744.1 8 93.02   
  Total 861.2 11    
      
Data summary      
  Number of treatments (columns) 4     
  Number of values (total) 12     




Table Analyzed Data 1     
      
ANOVA summary      
  F 83.02     
  P value < 0.0001     
  P value summary ****     
  Are differences among means statistically significant? (P < 0.05) Yes   
  
  R square 0.8098     
      
Brown-Forsythe test      
  F (DFn, DFd)      
  P value      
  P value summary      
  Significantly different standard deviations? (P < 0.05)      
      
Bartlett's test      
  Bartlett's statistic (corrected)      
  P value      
  P value summary      
  Significantly different standard deviations? (P < 0.05)      
      
ANOVA table SS DF MS F (DFn, DFd) P value 
  Treatment (between columns) 16516 4 4129 F (4, 78) = 83.02 P < 
0.0001 
  Residual (within columns) 3879 78 49.73   
  Total 20395 82    
      
Data summary      
  Number of treatments (columns) 5     
  Number of values (total) 83   
85 
 
B) Tukey Test of Leak Rates from Device vs Literature 
         
Number of families 1        
Number of comparisons per family 10        
Alpha 0.05        
         
Tukey's multiple comparisons test Mean Diff. 95% CI of diff. Significant?
 Summary     
         
  Device vs. SH 2.270 -9.923 to 14.46 No ns  A-B   
  Device vs. PR 1 -35.13 -47.32 to -22.94 Yes ****  A-C   
  Device vs. PR 2 -11.73 -23.92 to 0.4635 No ns  A-D   
  Device vs. PTFE -24.43 -36.62 to -12.24 Yes ****  A-E   
  SH vs. PR 1 -37.40 -43.63 to -31.17 Yes ****  B-C   
  SH vs. PR 2 -14.00 -20.23 to -7.772 Yes ****  B-D   
  SH vs. PTFE -26.70 -32.93 to -20.47 Yes ****  B-E   
  PR 1 vs. PR 2 23.40 17.17 to 29.63 Yes ****  C-D   
  PR 1 vs. PTFE 10.70 4.472 to 16.93 Yes ****  C-E   
  PR 2 vs. PTFE -12.70 -18.93 to -6.472 Yes ****  D-E   
         
         
Test details Mean 1 Mean 2 Mean Diff. SE of diff. n1 n2
 q DF 
         
  Device vs. SH 22.07 19.80 2.270 4.366 3 20 0.7352 78 
  Device vs. PR 1 22.07 57.20 -35.13 4.366 3 20 11.38 78 
  Device vs. PR 2 22.07 33.80 -11.73 4.366 3 20 3.799 78 
  Device vs. PTFE 22.07 46.50 -24.43 4.366 3 20 7.913 78 
  SH vs. PR 1 19.80 57.20 -37.40 2.230 20 20 23.72 78 
  SH vs. PR 2 19.80 33.80 -14.00 2.230 20 20 8.878 78 
  SH vs. PTFE 19.80 46.50 -26.70 2.230 20 20 16.93 78 
  PR 1 vs. PR 2 57.20 33.80 23.40 2.230 20 20 14.84 78 
  PR 1 vs. PTFE 57.20 46.50 10.70 2.230 20 20 6.785 78 




C) Paired T-Test for Pull-Out Tests 
 
Table Analyzed Paired t test data 
  
Column A Device 
vs. vs. 
Column B Suture 
  
Paired t test  
  P value 0.3151 
  P value summary ns 
  Significantly different? (P < 0.05) No 
  One- or two-tailed P value? Two-tailed 
  t, df t=1.329 df=2 
  Number of pairs 3 
  
How big is the difference?  
  Mean of differences -19.91 
  SD of differences 25.94 
  SEM of differences 14.98 
  95% confidence interval -84.36 to 44.54 
  R squared 0.4690 
  
How effective was the pairing?  
  Correlation coefficient (r) -0.9837 
  P value (one tailed) 0.0575 
  P value summary ns 
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